ORAL IRON CHELATING DRUGS - COMING BUT NOT YET READY FOR CLINICAL USE

被引:24
作者
HERSHKO, C
机构
关键词
D O I
10.1136/bmj.296.6629.1081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1081 / 1082
页数:2
相关论文
共 17 条
[1]   LONG-TERM CHELATION THERAPY IN THALASSEMIA MAJOR - EFFECT ON LIVER IRON CONCENTRATION, LIVER HISTOLOGY, AND CLINICAL PROGRESS [J].
BARRY, M ;
FLYNN, DM ;
LETSKY, EA ;
RISDON, RA .
BMJ-BRITISH MEDICAL JOURNAL, 1974, 2 (5909) :16-20
[2]  
ENGLE MA, 1964, ANN NY ACAD SCI, V119, P694
[3]   OXYGEN-TOXICITY, OXYGEN RADICALS, TRANSITION-METALS AND DISEASE [J].
HALLIWELL, B ;
GUTTERIDGE, JMC .
BIOCHEMICAL JOURNAL, 1984, 219 (01) :1-14
[4]  
HERSHKO C, 1984, J LAB CLIN MED, V103, P337
[5]  
HERSHKO C, 1981, J LAB CLIN MED, V98, P99
[6]  
HERSHKO C, IN PRESS TRACE ELEME
[7]  
KONTOGHIORGHES GJ, 1987, LANCET, V1, P1294
[8]   ORALLY ACTIVE ALPHA-KETOHYDROXY PYRIDINE IRON CHELATORS INTENDED FOR CLINICAL USE - INVIVO STUDIES IN RABBITS [J].
KONTOGHIORGHES, GJ ;
HOFFBRAND, AV .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (04) :607-613
[9]  
KONTOGHIORGHES GJ, 1987, BLOOD S, V70, pA48
[10]  
LEPLATTE.F, 1967, J AM CHEM SOC, V89, P837